One Jefferson News February 2018

Over the past year, we have continued our One Jefferson journey and achieved a number of integration successes for the organization. In the attached, new issue of One Jefferson News, we celebrate strides being made by collaborative teams working on evolving the Physician Enterprise, Access, Supply Chain, and System Integration initiatives. This issue includes: Changing the Way We Drive Enhanced Performance Collaborative Teams Accelerating Outcomeshttps://jdc.jefferson.edu/onejeffnews/1002/thumbnail.jp

One Jefferson News October 2017

Over the past month, we have continued our One Jefferson journey and achieved a number of integration successes for the organization as well as our patient and student communities. In this issue of One Jefferson News, we invite you to join us in celebrating the recent addition of Kennedy to Jefferson Health and a new college structure for Jefferson (Philadelphia University + Thomas Jefferson University) set to launch in 2018. During this time of continued organizational evolution, we recognize the importance of frequent communications and celebrating the many accomplishments of our talented team. If you have questions or ideas, we welcome you to email [email protected]. Thanks to all who have reached out to us with great input in support of the One Jefferson journey. We look forward to providing continued feedback and engaging in active dialogue. This issue includes: Jefferson and Kennedy Become One New College Structure at TJU Launches in 2018https://jdc.jefferson.edu/onejeffnews/1001/thumbnail.jp

One Jefferson News September 2017

Over the past three years, we have embarked on an exciting journey of reimagining a new model for health and education to create One Jefferson. Our first step was to bring together Thomas Jefferson University and Thomas Jefferson University Hospital. We continued along this journey by welcoming Abington Health and Aria Health, and combining Philadelphia University and Thomas Jefferson University. Recently, we also welcomed Kennedy Health to the Jefferson Health family. As the process of coming together – becoming one – continues to produce a growing number of integration successes for the organization, we are expanding communication efforts with this “One Jefferson” electronic newsletter. Emailed to all staff, the One Jefferson News update – through stories and images - will share how we are working together to fulfill our mission of improving lives in the communities we serve across the region. During this exciting time of rapid organizational evolution, we recognize the importance of frequent communications and celebrating the great things being accomplished by our talented team. If you have questions or ideas, we welcome you to email [email protected]. The account is actively monitored and we look forward to responding to you. Thank you for your interest and all you do each day to support the One Jefferson journey. This issue includes: Supply Chain/Purchased Services-Operational Initiative Update GE Healthcare Welcomes Jefferson Biomedical and Imaging Service Staffhttps://jdc.jefferson.edu/onejeffnews/1000/thumbnail.jp

The artisan and the artist. Innovation enables transformation

Technologies Excellence Group, for theCurriculum for Excellence Group for SG (commissioned by/for Mike Russell-Cabinet Secy on Education

SAFE Newsletter : 2013, Q3

Research: Joachim Weber, Benjamin Loos, Steffen Meyer, Andreas Hackethal "Individual Investors' Trading Motives and Security Selling Behavior" Ignazio Angeloni, Ester Faia "Monetary Policy and Prudential Regulations with Bank Runs" Helmut Siekmann "Legal Limits to Quantitative Easing" Policy Margit Vanberg "SAFE Summer Academy 2013 on 'International Financial Stability'" Guest Commentary Peter Praet "Cooperation between the ECB and Academia

When does NICE recommend the use of health technologies within a programme of evidence development?

This article is made available through the Brunel Open Access Publishing Fund. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.This article has been made available through the Brunel Open Access Publishing Fund.Background: There is growing interest internationally in linking reimbursement decisions with recommendations for further research. In the UK, the National Institute for Health and Clinical Excellence (NICE) can issue guidance to approve the routine use of a health intervention, reject routine use or recommend use within a research programme. These latter recommendations have restricted use to ‘only in research’ (OIR) or have recommended further research alongside routine use (‘approval with research’ or AWR). However, it is not currently clear when such recommendations are likely to be made. Objectives: This study aims to identify NICE technology appraisals where OIR or AWR recommendations were made and to examine the key considerations that led to those decisions. Methods: Draft and final guidance including OIR/AWR recommendations were identified. The documents were reviewed to establish the characteristics of the technology appraisal, the cost effectiveness of the technologies, the key considerations that led to the recommendations and the types of research required. Results: In total, 29 final and 31 draft guidance documents included OIR/AWR recommendations up to January 2010. Overall, 86 % of final guidance included OIR recommendations. Of these, the majority were for technologies considered to be cost ineffective (83 %) and the majority of final guidance (66 %) specified the need for further evidence on relative effectiveness. The use of OIR/AWR recommendations is decreasing over time and they have rarely been used in appraisals conducted through the single technology appraisal process. Conclusion: NICE has used its ability to recommend technologies within research programmes, although predominantly within the multiple technology appraisal process. OIR recommendations have been most frequently issued for technologies considered cost ineffective and the most frequently cited consideration is uncertainty related to relative effectiveness. Key considerations cited for most AWR recommendations and some OIR recommendations included a need for further evidence on long-term outcomes and adverse effects of treatment.Medical Research Counci

CGIAR Excellence in Breeding Platform - Plan of Work and Budget 2020

At the end of 2019, all CGIAR centers had submitted improvement plans based on an EiB template and in close collaboration with EiB staff while – in a parallel process with breeding programs, funders and private sector representatives – a vision for breeding program modernization was developed and presented to CGIAR breeding leadership at the EiB Annual Meeting. This vision represents an evolution of EiB in the context of the Crops to End Hunger Initiative (CtEH) beyond the initial scope of providing tools, services and expert advice, and serves as a guide for Center leadership to drive changes with EiB support. In addition, EiB has taken the role of managing and disbursing funding, made available by Funders via CtEH to modernize breeding and enable CGIAR breeding programs to implement the vision provided by EiB